Changes in retinal microvasculature and serum Gremlin-1 levels in acromegaly: A case-control study

被引:0
作者
Kocabas, Gokcen Unal [1 ]
Furundaoturan, Onur [2 ]
Degirmenci, Cumali [2 ]
Ozgur, Su [3 ]
Kocamanoglu, Meltem [4 ]
Arslan, Cigdem Gozde [4 ]
Koroglu, Esma Pehlivan [1 ]
Afrashi, Filiz [2 ]
Akcay, Yasemin [4 ]
Simsir, Ilgin Yildirim [1 ]
Yurekli, Banu Sarer [1 ]
机构
[1] Ege Univ, Internal Med Dept, Endocrinol & Metab Unit, Sch Med, Bornova, Turkiye
[2] Ege Univ, Sch Med, Ophtalmol Dept, Bornova, Turkiye
[3] WHO IARC GICR, Reg Hub Canc Registrat Northern Africa, Cent & Western Asia, Lyon, Turkiye
[4] Ege Univ, Sch Med, Med Biochem Dept, Bornova, Turkiye
关键词
Acromegaly; OCTA; Gremlin-1; Microvascular; Retina; GROWTH-FACTOR-I; VON-WILLEBRAND-FACTOR; HORMONE; INSULIN; SOMATOSTATIN; RETINOPATHY; EXPRESSION; NEOVASCULARIZATION; RESISTANCE; ENDOCRINE;
D O I
10.1016/j.pdpdt.2024.104415
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: There are controversial results about the effects of GH/IGF-1 on retinal vasculature. Gremlin-1 has roles in both pituitary tumorigenesis and angiogenesis. Therefore, we aimed to detect retinal micro-vascular changes in acromegaly with OCTA and examine its association with serum Gremlin-1 levels. Design: A cross-sectional, case-control study Methods: We included 53 acromegaly patients and age/gender-matched 31 healthy controls. To evaluate retinal structure, optical coherence tomography angiography (OCTA) imaging was performed. Gremlin -1 levels were measured by the ELISA method. Results: Acromegaly patients had significantly lower superficial total density (p < 0.001), superficial parafoveal density (p = 0.002), superficial perifoveal density (p < 0.001); deep total density (p < 0.001), deep parafoveal density (p < 0.001), deep perifoveal density (p < 0.001). Total thickness and perifoveal thickness were significantly lower in the acromegaly group. Gremlin-1 levels were significantly lower in acromegaly patients (1.22(0.13) vs 1.38(0.29); p = 0.015, for acromegaly and control groups, respectively). We assessed study groups based on glucose tolerance status. Normal glucose tolerance (NGT) acromegaly patients had significantly lower superficial total density (p = 0.036), superficial perifoveal density (p = 0.003), deep total density (p = 0.023), and deep perifoveal density (p = 0.023) compared to NGT controls. According to backward linear regression analysis, the presence of acromegaly itself consistently showed a significant negative impact on all types of vascular density. Conclusion: Patients with acromegaly have decreased vascular density and lower levels of Gremlin-1 independent of glucose tolerance status. Acromegaly may cause a reduction in gremlin-1 as a compensatory mechanism due to high IGF-1 levels known as an angiogenic factor, which in turn leads to the decrease in vascular density, or gremlin-1 may already have shown a decline in response to chronic inflammation and endothelial dysfunction in acromegaly resulting in a reduction in vascular density.
引用
收藏
页数:8
相关论文
共 45 条
  • [11] Multidisciplinary management of acromegaly: A consensus
    Giustina, Andrea
    Barkhoudarian, Garni
    Beckers, Albert
    Ben-Shlomo, Anat
    Biermasz, Nienke
    Biller, Beverly
    Boguszewski, Cesar
    Bolanowski, Marek
    Bollerslev, Jens
    Bonert, Vivien
    Bronstein, Marcello D.
    Buchfelder, Michael
    Casanueva, Felipe
    Chanson, Philippe
    Clemmons, David
    Fleseriu, Maria
    Formenti, Anna Maria
    Freda, Pamela
    Gadelha, Monica
    Geer, Eliza
    Gurnell, Mark
    Heaney, Anthony P.
    Ho, Ken K. Y.
    Ioachimescu, Adriana G.
    Lamberts, Steven
    Laws, Edward
    Losa, Marco
    Maffei, Pietro
    Mamelak, Adam
    Mercado, Moises
    Molitch, Mark
    Mortini, Pietro
    Pereira, Alberto M.
    Petersenn, Stephan
    Post, Kalmon
    Puig-Domingo, Manuel
    Salvatori, Roberto
    Samson, Susan L.
    Shimon, Ilan
    Strasburger, Christian
    Swearingen, Brooke
    Trainer, Peter
    Vance, Mary L.
    Wass, John
    Wierman, Margaret E.
    Yuen, Kevin C. J.
    Zatelli, Maria Chiara
    Melmed, Shlomo
    [J]. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2020, 21 (04) : 667 - 678
  • [12] Reduced microvascular perfusion and reactivity in adult GH deficient patients is restored by GH replacement
    Hána, V
    Prázny, M
    Marek, J
    Skrha, J
    Justová, V
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2002, 147 (03) : 333 - 337
  • [13] Growth hormone and ocular dysfunction: Endocrine, paracrine or autocrine etiologies?
    Harvey, Steve
    Martinez-Moreno, Carlos G.
    [J]. GROWTH HORMONE & IGF RESEARCH, 2016, 29 : 28 - 32
  • [14] The Novel Adipokine Gremlin 1 Antagonizes Insulin Action and Is Increased in Type 2 Diabetes and NAFLD/NASH
    Hedjazifar, Shahram
    Khatib Shahidi, Roxana
    Hammarstedt, Ann
    Bonnet, Laurianne
    Church, Christopher
    Boucher, Jeremie
    Blueher, Matthias
    Smith, Ulf
    [J]. DIABETES, 2020, 69 (03) : 331 - 341
  • [15] Reduced retinal vascularization in children with growth hormone deficiency
    Hellström, A
    Svensson, E
    Carlsson, B
    Niklasson, A
    Albertsson-Wikland, K
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (02) : 795 - 798
  • [16] Gremlin gene expression in bovine retinal pericytes exposed to elevated glucose
    Kane, R
    Stevenson, L
    Godson, C
    Stitt, AW
    O'Brien, C
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2005, 89 (12) : 1638 - 1642
  • [17] Evaluation of Ocular Hypoperfusion in Patients with Acromegaly by Using Optical Coherence Tomography Angiography
    Karahan, Mine
    Demirtas, Atilim Armagan
    Erdem, Seyfettin
    Ava, Sedat
    Pekkolay, Zafer
    Keklikci, Ugur
    [J]. CURRENT EYE RESEARCH, 2021, 46 (08) : 1209 - 1213
  • [18] Acromegaly: An Endocrine Society Clinical Practice Guideline
    Katznelson, Laurence
    Laws, Edward R., Jr.
    Melmed, Shlomo
    Molitch, Mark E.
    Murad, Mohammad Hassan
    Utz, Andrea
    Wass, John A. H.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (11) : 3933 - 3951
  • [19] Khachatryan V, 2016, J HIGH ENERGY PHYS, DOI 10.1007/JHEP10(2016)006
  • [20] Gremlin, a Bone Morphogenetic Protein Antagonist, Is a Crucial Angiogenic Factor in Pituitary Adenoma
    Koketsu, Kenta
    Yoshida, Daizo
    Kim, Kyongsong
    Ishii, Yudo
    Tahara, Shigeyuki
    Teramoto, Akira
    Morita, Akio
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2015, 2015